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Abstract
Background: Retinol isotope dilution (RID) methodology provides a quantitative estimate of
total body vitamin A (VA) stores and is the best method currently available for assessing VA
status in adults and children. The methodology has also been used to test the efficacy of VA
interventions in a number of low-income countries. Infections, micronutrient deficiencies (eg,
iron and zinc), liver disease, physiological age, pregnancy, and lactation are known or hypo-
thesized to influence the accuracy of estimating total body VA stores using the isotope dilution
technique.
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Objective: Our objectives were to review the strengths and limitations of RID methods, to discuss
what is known about the impact of various factors on results, and to summarize contributions of
model-based compartmental analysis to assessing VA status.
Methods: Relevant published literature is reviewed and discussed.
Results: Various equations and compartmental modeling have been used to estimate the total body
VA stores using stable isotopes, including a newer 3-day equation that provides an estimate of total
body VA stores in healthy adults. At present, there is insufficient information on absorption of the
isotope tracer, and there is a need to further investigate how various factors impact the application of
RID techniques in field studies.
Conclusions: Isotope dilution methodology can provide useful estimates of total body VA stores in
apparently healthy populations under controlled study conditions. However, more research is needed
to determine whether the method is suitable for use in settings where there is a high prevalence of
infection, iron deficiency, and/or liver disease.
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Introduction
Vitamin A (VA) is an essential nutrient that is
required for normal vision, reproduction, growth,
and immune health. Vitamin A deficiency (VAD,
defined as plasma retinol concentrations <0.7
mmol/L) affects an estimated 190 million
preschool-aged children and 19.1 million preg-
nant women globally, which correspond to
33.3% of the preschool-aged population and
15.3% of pregnant women in populations at risk
of VAD.1
Eradication of VAD remains an important goal
for public health professionals worldwide, and
providing VA is one of the most cost-effective
health interventions known.2 Evaluation of such
interventions is important to ensure that optimal
levels of total body VA are achieved but not
exceeded,3 especially in countries where more
than one public health intervention to control
deficiency is in place.2,4,5 Concerns have been
raised about inadvertent chronic excessive VA
intakes due to high-dose VA supplementation
combined with concurrent use of VA-fortified
foods, micronutrient powders (MNPs), and
voluntarily fortified commercial products.2,4 Ele-
vated hepatic VA concentrations (>1 mmol/g
liver) have been reported in a small study of
Nicaraguan schoolchildren 1 year after imple-
mentation of sugar fortification3 and in Zambian
children exposed to supplementation and
fortification.6 To determine whether public health
intervention programs place some individuals at
risk of excessive VA intake, sensitive biomarkers
are needed to evaluate the effectiveness and
safety of VA interventions across the full spec-
trum of VA status, especially because plasma
concentrations of retinol show limited respon-
siveness to changes in status in populations with
adequate or excessive VA intakes.3,7 The retinol
isotope dilution (RID) technique can be used to
(a) assess total body stores of VA, (b) detect
quantitative changes in response to interventions,
(c) assess the efficacy of provitamin A food-based
interventions, and (d) estimate VA requirements.8
The benefits and limitations of the technique and
associated mathematical calculations, as well as
the independent method of compartmental analy-
sis, are discussed in this review.
Evolution of Stable Isotope Dilution
Techniques for Determining VA
Status in Population Groups
Over time, many methods have been proposed for
estimating VA status, but none of these are fully
satisfactory.9 Most of the body’s VA is stored in
the liver in well-nourished individuals,10 and
thus, direct measurement of liver VA concentra-
tion is a good indicator of VA status in these
individuals. In contrast, in rats with low VA
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status, about 90% of total body VA is stored in
nonhepatic tissues,11 and therefore, liver VA con-
centrations would not reflect the total body VA
stores. The contribution of nonhepatic tissues to
VA status in humans with low VA status is cur-
rently not known. Furthermore, direct sampling
of liver can only be accomplished in exceptional
circumstances.12,13 Despite these limitations,
liver VA concentrations are still being used to
define VA status, and the most common cutoff
is >0.07 mmol/g (>20 mg/g) as adequate.9,14
Beyond liver VA concentrations, the distribu-
tion of plasma retinol concentration in a popula-
tion has traditionally been used to provide useful
information about the VA status of that popula-
tion and their response to VA interventions15,16;
use of this index is discussed further in paper 2 of
this series. However, plasma retinol is under
homeostatic control and is maintained over a
wide range of liver VA stores, and thus, it is not
a sensitive indicator of VA status in individuals.
Nevertheless, at the population level, a shift in the
distribution of plasma retinol concentrations can
be used to assess changes in VA status over time
or in response to an intervention,7 if there is a
high prevalence of low serum retinol concentra-
tions initially. In addition to liver and plasma VA
measurements, there are functional assessments
of VA status, such as impaired dark adaptation
and night blindness. Night blindness is assessed
by interview, and dark adaptation can be assessed
objectively in field settings, but both may be pro-
blematic to assess accurately, especially in popu-
lation groups most at risk, such as very young
children. Finally, the relative dose–response and
modified relative dose–response tests have pro-
ven useful in identifying individuals with inade-
quate liver VA stores but do not provide
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Figure 1. The principle of the retinol isotope dilution (RID) technique. A, A known dose of stable isotope-labeled
vitamin A is administered orally. B, This is followed by an adequate mixing period during which the labeled vitamin
A mixes with the endogenous nonlabeled vitamin A pool. C, Finally, a blood sample is obtained for measurement
of the plasma or serum isotopic ratio of labeled to nonlabeled retinol.
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quantitative measures of total body VA
stores.17,18
Isotope dilution methods have been used to
evaluate VA status. The RID technique is respon-
sive to supplementation with VA and has been
used successfully in apparently healthy adults and
children in low-income countries to assess the effi-
cacy of various VA interventions.3,19-25 In appar-
ently healthy Bangladeshi men, total body VA
stores responded in a dose-dependent manner to
3 different daily doses of VA (0, 1.5, or 3.0 mg/d
for 75 days), suggesting that the RID technique
could be used to detect quantitative changes in
response to interventions.20 Furthermore, the RID
technique has been used to assess the efficacy of
provitamin A food-based interventions in both
clinical and community settings in low-income
countries.6,21-24 In addition to assessing the effi-
cacy of interventions, the RID technique has been
used to estimate VA requirements in Bangladeshi
men26 and, more recently, in women from the
United States.27 Thus, the RID technique is clearly
useful for evaluating interventions in controlled
studies of apparently healthy adults and children.
The RID method is based on the oral adminis-
tration of a small dose of tracer-labeled VA fol-
lowed by the determination of the tracer to tracee
(unlabeled VA) ratio in plasma using mass spec-
trometry. The ratio is measured after a suitable
period for mixing of the tracer with the total body
VA pool (Figure 1). Currently, a blood sample is
collected at 11 to 26 days after dosing with stable
isotope-labeled VA.28,29 However, reevaluation
of earlier studies, coupled with recent work, indi-
cates that total body stores of VA can be assessed
bymeasuring the tracer to tracee ratio in serum at 3
days after administration of a physiological dose
of stable isotope-labeled VA.30 The stable iso-
topes that are used as tracers in the RID technique
can be either 2H or 13C. The size of the dose
depends on the target group (infants, children, or
adults) and the limit of detection of the analytical
method being used tomeasure the ratio of tracer to
tracee in plasma. In early studies, pharmacological
doses of 2H4-retinyl acetate were used in adults
(20-45 mg).12,13,31 However, smaller physiologi-
cal doses are desirable for evaluating nutritional
status by RID techniques because this minimizes
perturbations of endogenous retinoid pools and
limits departure from steady-state kinetics during
metabolism of the tracer.32 Furthermore, adminis-
tration of smaller doses reduces costs and thus
facilitates use of the technique in studies with
larger sample sizes.8
Various types of mass spectroscopy are used
to measure enrichment of stable isotope-labeled
VA in plasma,33 including gas chromatography–
mass spectrometry and gas chromatography fol-
lowed by electron capture negative chemical
ionization/mass spectrometry,32,34 gas chroma-
tography/combustion/isotope ratio mass spec-
trometry (GC/C/IRMS; used for 13C/12C
determination),35-37 or more recently, liquid
chromatography coupled with tandem triple
quadmass spectrometry with atmospheric pressure
chemical ionization in positive ion mode.38-40 The
analytical sensitivity of mass spectrometers has
increased greatly in the past 3 decades, and it is
now possible to measure isotopic enrichment in
plasma after administration of a small, physiologic
oral dose of stable isotope-labeled VA (Figure 2).
Calculation of Total Body Stores of
VA Using Stable Isotope Data
Three methods are used for calculating VA status
using stable isotope data. Two isotope dilution
Figure 2. Sizes of vitamin A tracer doses administered
for isotope dilution studies (compiled from published
reports3,6,12,13,19-22,25-29,31,38,41-48).
S90 Food and Nutrition Bulletin 37(2S)
methods are based on analytical equations
(‘‘Olson’’ and ‘‘mass balance’’ equations as
described subsequently and in Table 1), and the
third uses model-based compartmental analysis.
Background information, assumptions, and math-
ematical adjustments used for both analytical
equation methods will first be discussed, fol-
lowed by a brief review of the modeling
approach.
The RID technique was first used to estimate
body VA status in rats,49,51,52 as summarized by
Bausch and Rietz.53 When the prediction equa-
tion developed by Rietz et al was applied to
human data, the agreement between calculated
and measured liver VA stores (determined from
liver biopsy samples) was not satisfactory, and
an alternate equation, often referred to as the
‘‘Olson equation,’’ was proposed (see Equation
1 in Table 1).12 The application of this equation
was corroborated by Haskell et al in a study in
Bangladeshi adults.13 Most subsequent human
studies have used variations of this equation for
calculating total body or liver stores of VA
(reviewed by Furr et al33). The mass balance
equation (Equations 2-4 in Table 1) is the basis
for the 13C2-RID method calculations.
36 This
technique requires a baseline blood sample in
at least a few individuals to determine the
natural abundance of 13C and a subsequent
blood sample to analyze 13C-enrichment by
GC/C/IRMS.6,27,35,36 It is important to note that
work is ongoing to refine constants of the pre-
sented equations to verify their accuracy and
utility in predicting VA stores under different
circumstances.
Both analytical equations are best applied to
evaluate VA status of groups rather than individ-
uals due to the fact that large interindividual var-
iations in VAmetabolism have been observed.8,54
Importantly, several mathematical adjustments
are needed to convert the tracer data to VA pool
size estimates. First, an adjustment is required
because some of the tracer dose never enters the
endogenous VA pool. Thus, a correction factor is
necessary to account for the inefficiency of the
absorption and storage of the tracer dose. In rats
and sheep, 50% of an oral VA dose was recovered
in liver at the time of sampling,53 which is why
this value has been used to correct the equations
for use with human data. Incorrect estimation of
tracer absorption and storage can lead to overes-
timation of total body stores if absorption is esti-
mated as higher than actual and underestimation
if absorption is estimated as lower than actual.
Reported tracer absorption in healthy children
ranges from 76.5% to 99.2%, whereas retention
of tracers (retention here means absorbed tracer
minus loss of tracer through bile and urinary
excretion during the first several days after dose
administration) has been reported to be between
71.1% and 82.2%.41,55 Lower retention was
attributed to excretion of 5.4% to 17.0% of the
administered tracer dose in the urine.41,55
Furthermore, average absorption and retention
were significantly reduced (to 74.3% and
57.6%, respectively) in Indian children with
infections (ie, respiratory infection, enteric fever,
and gastroenteritis), with 10% to 70% of the
administered label appearing in the feces.55 Thus,
it seems prudent to adjust for reduced absorption
efficiency under conditions of infection. How-
ever, because there are insufficient data to deter-
mine appropriate correction factors for different
types and severity of infections, individuals with
symptomatic illness should be excluded from
studies using RID techniques.
A second correction is required to account for
the ongoing metabolism of VA because some of
the tracer dose will be metabolized during the
mixing period. Although adequate time for mix-
ing among metabolic pools of VA must be
allowed, sampling should occur as soon as possi-
ble after dose administration to minimize these
effects. Using a VA fractional catabolic rate (ie,
the percentage of the available VA body pool that
is lost per day; 0.5%/day for adults56), either
98.5% or 89.5% of the absorbed dose is still pres-
ent at 3 or 21 days after administration of the
tracer, respectively. However, a higher fractional
catabolic rate of 2.2%/day was found in Peruvian
children,42 leaving 93.4% or 53.8% of the
absorbed dose still present at 3 or 21 days, respec-
tively. Thus, earlier time points are beneficial in
determining total body stores of VA because
more of the tracer will still be present and smaller
sample volumes can be used for laboratory anal-
ysis. Moreover, shorter study periods will likely
reduce the burden on study participants.
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A third correction factor is required to account
for the differential distribution of tracer and tra-
cee in body tissues and plasma. In other words,
the ratios of tracer molecules to tracee molecules
in the body tissues versus plasma are not identi-
cal.13,50,57 Generally, after a dose of labeled VA
has mixed in the body, there is a higher pro-
portion of tracer to tracee in the storage pool
compared with plasma. The ratio of plasma
retinol-specific activity to storage VA-specific
activity after adequate time for mixing (7 days)
was estimated from rat experiments to be 0.65 by
comparing specific activity in serum to specific
activity in liver.50 This value appears to be fairly
consistent when liver VA stores are adequate;
however, at very low liver VA concentrations50
and 3 days after administration,30 this value
appears to be closer to 1 (ie, retinol-specific activ-
ities in plasma and stores are about the same).
This will also be the case if dietary VA intake
is eliminated after the tracer is given.36 In this
scenario, the system goes into a quasi-isotopic
equilibrium because the specific activity in all
compartments will become equal, despite the fact
that loss is still occurring. However, complete
elimination of dietary VA intake for the period
between isotope administration and blood collec-
tion to determine the tracer to tracee ratio cannot
be achieved under field conditions.
Although these approaches are useful for pro-
viding an estimate of VA status under usual con-
ditions,12,13,19,27,42 several modifications of the
methods would enhance their utility and applic-
ability in other physiological states, such as
hypervitaminosis A. The fractional catabolic rate
of VA is currently used to adjust for irreversible
VA loss, and this adjustment is made with a con-
stant fractional loss of 0.5%/day based on the data
of Sauberlich et al.56 However, VA utilization
rate depends on VA status,58-61 iron status,62
inflammatory state,63 and life stage.42 Thus, to
be more broadly applicable, the correction for
Table 1. The Olson and Mass Balance Equations for Estimating Total Body Stores of VA Using Stable Isotope
Methodology.
Olson equationa
1. Total liver reserves ¼ F  dose (S  a  [(H:D)  1])
Equation 1 is the form of the isotope dilution equation published by Furr and colleagues in 1989.12 F is a factor to
express efficiency of storage (estimated to be 0.549); S is the ratio of specific activity of retinol in plasma to
specific activity of VA in liver (taken as 0.65 from a rat study50); a is the fraction of absorbed tracer dose
remaining in body at time t after dosing (a ¼ ekt, using an estimated rate of catabolism of VA for adults; k ¼
[ln 2]/140 days ¼ 0.00495 per day); H:D is the isotope ratio of nondeuterated (tracee) to deuterated (tracer)
retinol in plasma; and the term ‘‘1’’ is used to correct for the contribution of the mass of the tracer dose to the
total VA stores (not needed when the tracer dose is small)
Mass balance equationa
2. (Fa  a) þ (Fb  b) ¼ (Fc  c)
3. c ¼ a þ b
4. b ¼ a FaFcFcFb
5. Total body reserves ¼ b  ekt
Equation 4 is the form of the mass balance equation used for calculating VA stores by Tanumihardjo in 2000.36 Fa is
the isotope abundance of 13C in the isotopic dose; a is the amount of the absorbed isotopic dose (dose 
absorption efficiency); Fb is the isotope abundance of
13C in the endogenous VA pool; b is the amount of the
endogenous VA pool at baseline; Fc is the isotope abundance of
13C in the total VA pool (F ¼ 13C/[12C þ 13C])
after dosing; c is the amount of the total VA pool after dosing; k ¼ ln(2)/metabolic half-life of retinol in days; t¼
time after dosing in days. The values of Fc and Fb are determined by GC/C/IRMS before (Fb) and after the dose
(Fc). The terms b and c are unknowns. Equations 2 and 3 can be rearranged to solve for b in terms of known and
measured factors, yielding Equation 4
Abbreviations: GC/C/IRMS, gas chromatography/combustion/isotope ratio mass spectrometry; VA, vitamin A.
a The Olson and mass balance equations are presented as published previously, but their accuracy and utility for different
circumstances are still being evaluated.
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irreversible loss should be situation dependent.
Alternatively, if a shorter time period can be used,
the influence of catabolic loss on the determina-
tion of total body VA status will be reduced.
Finally, it will be important to be assured that
both the Olson equation and the mass balance
method provide similar estimates of total body
stores of VA. Direct comparisons between these
methods are currently lacking.
An alternative to using prediction equations
for estimating VA status is compartmental mod-
eling, which provides kinetic information in addi-
tion to VA pool size. Compartmental modeling
also allows for substantial improvements in the
various correction factors needed to transform the
basic principles of isotope dilution to equations
that can handle the complexities of VAD and
possibly toxicity in different stages of life and
in different disease states. However, this
technique requires the collection of multiple
blood samples at defined time points over a rela-
tively long duration, combined with the need for
expertise in analyzing and modeling the
data.58,61-64 Since the 1980s, model-based com-
partmental analysis has been used to describe and
quantitate VA metabolism in rodent models (for
reviews, see65 and66) and, more recently,
humans.30,38,58 Quantification of exchangeable
total body VA stores using model-based compart-
mental analysis has been performed in humans
after oral administration of stable isotopes of deu-
terium58 or 13C30,38 over a duration of 52 and 14
days, respectively. After converting plasma tracer
response data to fraction of administered dose
versus time, modeling using the Simulation,
Analysis and Modelling software,67 and fitting
to a 6-component model (Figure 3), the total
amount of VA stores (mean + SD) was
Figure 3. Six-component model for vitamin A (VA) kinetics in humans. Circles represent compartments; com-
ponent 3, shown as a rectangle, is a delay element, and interconnectivities between compartments (L[I, J]s) are
fractional transfer coefficients or the fraction of retinol in compartment J that is transferred to compartment I
each day. Compartments 1 to 4 (including component 3) correspond to VA digestion and absorption, chylomicron
production and metabolism, liver uptake of chylomicron remnant retinyl esters, and hepatic processing of retinol.
Compartment 5 represents plasma retinol bound to retinol-binding protein and transthyretin. This retinol
exchanges with VA in one extravascular pool (compartment 6), which includes liver VA stores. The asterisk
represents the site of input of an orally administered stable isotope of VA, and U(1) represents dietary VA input.
Adapted from Cifelli et al.65
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calculated as 233 + 109 mmol for 14 Chinese
participants,58 892 + 637 mmol for 12 Ameri-
cans,58 and 114 + 72 mmol for 33 UK partici-
pants.30,38 An expedient approach in the future
may be to strategically design isotope/compart-
mental modeling experiments to determine key
pieces of information. These studies could inform
development of simpler calculation methods that
require fewer blood samples for field situations
when multiple blood collections combined with
compartmental modeling are not feasible.
Current Limitations of the Isotope
Dilution Technique
The RID technique has been validated in adults
on the basis of liver VA concentration and mod-
ified for use in preschool- and school-aged chil-
dren.12,28,42 The validation studies in adults
indicated that the RID technique provides an
accurate estimate of liver VA stores for groups
of individuals, but it does not provide a precise
estimate of liver VA stores for individual partici-
pants.12,13 Plasma retinol kinetics of an oral dose
of stable isotope-labeled VA has not yet been
described in infants <12 months of age or in preg-
nant and lactating women.1,8 More information is
needed on VA turnover rates in these population
subgroups to modify the RID technique and pre-
diction equations. This is important because
infants and pregnant and lactating women are at
risk of VAD and its consequences in low-income
countries, and many interventions are targeted to
these subgroups.1,8 The RID technique could be a
useful tool for testing the efficacy of interventions
in these subgroups.
As mentioned earlier, the RID technique is
dependent on absorption, distribution, mixing,
and disposal of a labeled VA dose. It is not known
whether the technique provides an accurate esti-
mate of total body VA stores in populations with
high rates of infection and micronutrient deficien-
cies that may affect VA metabolism. Absorption
and retention of labeled VA are primary concerns
during acute infection, particularly as more sen-
sitive analytical techniques enable investigators
to use smaller tracer doses. Diarrhea, parasitic
infections, and febrile illnesses are all known to
reduce VA absorption.55,68-71 This effect does not
appear to be limited to acute infection but rather
extends into the period following recovery. Data
from Zambia, for example, illustrate a significant
reduction in absorption of a tracer dose in the case
of recently reported fever.41 Systemic febrile
infections also increase VA utilization and excre-
tion.55,72 The association between hyporetinole-
mia and inflammation73 can be explained by
decreased synthesis of retinol-binding protein
(RBP) in the liver74 and, consequently, reduced
hepatic mobilization of retinol.63,75 Modeling
revealed an effect of inflammation on both the
mobilization of VA and on the tracer to tracee
ratio in the plasma compartment.63 This
inflammation-induced change in specific activity
could lead to overestimation of VA pool size by
the RID technique.66 The magnitude of this effect
is likely to depend on the timing of the specific
activity measurement and, potentially, the nature
of the stressor. Much of the research in this area
focuses on the normalization of plasma retinol
concentration following resolution of the inflam-
matory insult,76-78 similar to what was modeled
by Gieng and colleagues.63 Thus, the extent to
which chronic, low-grade inflammation influ-
ences retinol mobilization, or potential conse-
quences for prolonged sequestration in the liver,
requires further investigation.
Vitamin A metabolism is also known to be
affected by iron deficiency. Specifically, studies
in pregnant women have shown greater improve-
ments in the relative dose–response test and in
dark adaptation when VA was coadministered
with iron or iron plus riboflavin, compared with
VA supplementation alone.79,80 Reduced plasma
retinol concentrations have been observed in ane-
mic rats,81 even when animals were fed a VA-rich
diet,82 and are associated with VA accumulation
in the liver and a higher molar ratio of liver reti-
nyl esters/retinol.82,83 These relationships have
also been investigated by model-based compart-
mental analysis, which showed decreased absorp-
tion of VA and inhibited mobilization of VA
stores in diet-induced iron deficiency in rats.62
Furthermore, the activity of the key enzyme
in provitamin A conversion, b,b-carotene
15,150-dioxygenase, is iron dependent.84,85
These results underscore the importance of con-
sidering iron status in RID studies to calculate
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total body VA stores because iron deficiency
with or without anemia may influence the
amount of tracer in the plasma, leading to an
incorrect estimation of pool size.
Interactions between zinc and VA have long
been recognized; however, research regarding the
impact of zinc deficiency on VA metabolism is
inconclusive.86 Animal research suggests a role
for zinc in intestinal absorption of VA, mobiliza-
tion from the liver, and cellular uptake, all of
which may be compromised during zinc defi-
ciency.87-90 Observational studies have also high-
lighted a direct association between zinc status
and plasma retinol concentration.91,92 However,
it is unclear whether these associations were the
result of zinc deficiency or other associated fac-
tors. Of 4 randomized, controlled trials to con-
sider this question, 2 reported a significant
increase in serum retinol concentrations with zinc
supplementation alone.93,94 This discrepancy
from the other 2 trials95,96 may be related to base-
line nutritional status, as the effect of zinc sup-
plementation was greater in children deficient in
zinc or VA, and previous research supports an
effect primarily among children with moderate
to severe protein energy malnutrition and/or low
baseline zinc status.93,97
Detection and Consequences of
VA Toxicity
Hypervitaminosis A is an issue of potential con-
cern in low- and middle-income countries, where
children may be exposed to multiple VA inter-
ventions, including high-dose supplements, forti-
fied foods, and, to a lesser extent, MNP.2,4,5
Chronic excessive VA intake can create liver
abnormalities, including perisinusoidal fibrosis
and hypertrophy and hyperplasia of stellate cells,
which are key effector cells in the evolution of
fibrosis and cirrhosis.4,98,99 These changes result
in obstruction of blood flow through the liver.
Because clinical signs and symptoms occur late
in the course of VA intoxication and the conse-
quences are severe, it is important to identify
early and reliable biomarkers that indicate when
VA overload is occurring but before any clinical
sequelae have developed.
Circulating retinyl esters have, to date, been
the most widely used biomarker to indicate VA
intoxication. Normal fasting retinyl ester con-
centrations are <70 to 100 mg/L, and the ratio
of retinyl esters to total retinol plus retinyl
esters is <0.08.100-102 In addition to VA intox-
ication, higher than normal circulating concen-
trations of retinyl esters may be seen
transiently in the postprandial state after a
VA-rich meal or may indicate underlying liver
disease (ie, failure of the liver to take up newly
absorbed retinyl esters from the circulation
and/or inappropriate release of retinyl esters
from the liver’s storage cells, known as stellate
or Ito cells). High levels of circulating retinyl
esters may also be seen in hypertriglyceridemia
because newly absorbed retinyl esters are car-
ried in the circulation on chylomicron rem-
nants.103 In VA intoxication, retinyl esters
may represent as much as 70% of total circu-
lating VA.104 However, a quandary arises in
interpreting retinyl ester values in geographic
localities where there is a high prevalence of
underlying liver disease (particularly hepatitis).
In this situation, high levels of retinyl esters in
plasma may indicate VA intoxication, but they
may also reflect an inappropriate release of
retinyl esters into the circulation due to liver
inflammation (from hepatitis) or impaired
hepatic uptake of retinyl esters after a meal
by an inflamed liver.105 Also, because high
retinyl ester values may correlate with abnor-
mal liver function (ie, transaminase levels in
blood), even in populations with low hepatitis
prevalence, the reliability of retinyl ester levels
as a biomarker for excessive intake is question-
able. As mentioned in paper 1 of this series,
when investigating the retinol to RBP ratio as a
biomarker for VA intoxication, synthesis of
RBP in the liver may become impaired in an
inflamed liver, potentially influencing this
ratio.
Although there are concerns about an
increased risk of bone fracture, even when pre-
formed VA intake is less than the upper intake
level of 3000 mg/d,5 the link between a higher
incidence of fractures, lower bone mineral den-
sity, and higher VA intakes remains speculative
due to methodological issues related to the
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accurate assessment of VA intake and status.
Furthermore, high VA intakes were only asso-
ciated with a modest increase in total fracture
risk in women with low vitamin D intake (<11
mg/d).106 Even though exposure to increasing
doses of VA in animal models induced a pro-
gressive calcification of the epiphyseal-resting
zone, followed by bony tissue replacement and
then complete disappearance of the growth
plate,107-109 it is still not clear whether these
detrimental effects occur at usual intakes of
<3000 mg/d.
Although the RID technique has been applied
to measure the full range of status in populations,
there were discrepancies between measured and
predicted total body stores in rhesus monkeys
with hypervitaminosis A.35 Both the RID test and
compartmental modeling underestimated total
body VA stores. This was largely due to limited
exchange of extravascular VA with the tracer,
indicating that most of the measured VA was
in pools that did not exchange with plasma.35
When VA status is high, lipid droplet size
increases and morphology changes in the liver
stellate cells110; thus, it is not surprising that all
of these droplets do not readily exchange with
plasma retinol. The enlargement of stellate cells
due to high VA stores may protect the liver from
fibrogenesis.111 High VA concentrations induce
perisinusoidal fibrosis and hypertrophy and
hyperplasia of stellate cells. Because of these
quandaries, additional biomarker development
for VA intoxication is needed. Identifying bio-
markers that would change as VA overload is
approached but before the occurrence of organ
damage is essential.
Important Considerations for
Population-Based Assessments of
VA Status
The RID technique is currently being proposed
for use in population-level VA status assessments
as well as being used to monitor and evaluate
interventions, justified by its utility across the full
range of VA status.9 To date, the primary goal of
population status assessments has been to identify
groups at risk of deficiency. Guidelines are
available for the design, implementation, and
analysis of assessments using plasma retinol or
RBP,112 as are several decades of data that enable
program managers and policy makers to track
progress toward VAD control1 that can be used
to guide interpretation.8,73
Population assessments require choosing a
representative sample in order to accurately
describe status and/or draw inferences about
burden, such as the proportion of children
with excessive liver stores. In RID studies
undertaken to date, researchers have screened
out participants with febrile illness or diarrhea
in the past day or week,3,13,21,26-29,41,42,43 liver
disease,13,27,28,43,113,114 other chronic dis-
eases,3,26,41,44,113,115 and helminthiasis113
because these conditions are likely to affect the
absorption and/or retention of the tracer dose or
otherwise alter the VA metabolism.8 However,
in the context of a population status assessment,
removing certain individuals as a result of
screening is likely to introduce bias. Efforts can
be made to control some conditions, such as
through the presumptive treatment of intestinal
helminthiasis 1 week prior to tracer dos-
ing.7,13,28 Data on other factors, such as recent
infections and chronic disease history, should be
collected and considered in analyses. Measure-
ment of inflammatory proteins such as
C-reactive protein or a1-acid glycoprotein, as
well as both iron and zinc status indicators, is
also recommended to test for potential effect
modification.8 Previous RID studies have con-
sidered chronic liver conditions in their study
design.13,27,28,43,113,114 Although the etiology of
liver disease may differ in low- and middle-
income countries, viral hepatitis,116,117
malaria,118-120 and aflatoxin intoxication121 are
all characterized by hepatic dysfunction. Fur-
ther research is clearly needed to guide the
application and interpretation of RID methods
for population status assessments in cases of
acute infection, chronic inflammation, other
micronutrient deficiencies, and exposure to hepa-
tic insults. Researchers should consider the
potential influence of highly prevalent liver con-
ditions122-124 on VA metabolism, including
potential confounding effects on VA status
assessment.
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Conclusions and Future Directions
The use of stable isotopes in various aspects of
VA biology is powerful, and stable isotope meth-
ods have been successfully applied in healthy
adults and children to assess the efficacy of var-
ious VA and provitamin A food-based interven-
tions in both clinical and community settings in
low-income countries. In addition, the technique
has been successful in estimating VA require-
ments. However, a number of factors must be
considered before recommending the RID tech-
nique for use in population status assessments.
We currently lack a standardized methodology
with regard to isotope selection, appropriate
doses for various target groups, the timing of
blood sampling(s) relative to dosing, and calcula-
tion of total body stores. This limits our ability to
compare results across studies or to follow trends
over time. Future work in this area should encour-
age methods requiring only one blood collection,
which would significantly ease logistics and
likely increase compliance in the field.
Uncertainty currently exists in the way to cal-
culate total body stores of VA. Factors such as
absorption of the tracer, its metabolism, and the
different distribution between the plasma and
storage compartments need to be taken into con-
sideration. Inflammation and specific micronutri-
ent deficiencies reduce absorption efficiency of
the isotope dose; thus, it is currently recom-
mended to exclude participants with identified
inflammatory responses. Future studies are
needed to address this uncertainty of tracer
absorption by measuring the tracer concentration
in feces. However, to enable better monitoring of
these confounding factors, on-site evaluation of
micronutrient deficiencies and inflammation com-
bined with early blood sampling (eg, 3 days after
administration of the tracer dose) may be recom-
mended. Although physiological levels of tracers
are recommended and currently used, it is not clear
what amount should be administered in various
age-groups and to what extent the amount of admi-
nistered isotope influences the determination of
total body stores. Improvements in mass spectro-
meters may lead to detection methods that can be
performed on small blood volumes, which will be
especially important for studies in young children.
Chronic excessive VA intake has been cited as
a potential concern in communities exposed to
multiple VA interventions, including high-dose
supplements, fortified foods, and MNP. Early
biomarkers to predict VA overload before any
organ damage occurs are urgently needed.
Although the RID technique has been proposed
to detect VA status from deficiency through toxi-
city, there are concerns that the method may be
compromised at high VA liver concentrations due
to increased storage of tracee in lipid droplets in
liver stellate cells, resulting in reduced exchange
between the liver and plasma tracer pools. Further
developments of new potential biomarkers of
hypervitaminosis A, such as bone or liver fibrosis
markers, are therefore required.
Published RID studies have generally relied on
highly skilled individuals to prepare doses and
administer the isotope to research participants.
In order to implement a population-level status
survey, clear guidelines on staffing requirements,
training, and supervision are needed. Thus,
although RID methodology is becoming more
widely applied, remaining questions related to its
implementation and interpretation in population-
based field studies need to be addressed, especially
in settings where infections and micronutrient
deficiencies are common.
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